Skip to content
DataLookout
Menu

Joshua Brody clinical trial pipeline

Get alerts when Joshua Brody's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: Ibrutinib and Pembrolizumab · Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL) Primary completion pushed from Nov 2025 to Apr 2027 Joshua BrodyPhase 1/2 NCT03153202
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1/2
1
Phase 2
1

Disease areas by active trials

Get alerts when Joshua Brody's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free